RSV is the leading cause of viral bronchiolitis and pneumonia worldwide, infecting more than 50 percent of children in their first year of life and nearly 100 percent by age 2.
Oblato, Inc., has acquired all rights from OMRF to OKN-007, an investigational drug for the treatment of a deadly form of brain cancer.
Cancer often returns after successful therapy, but why?
OMRF researchers found mutations in PDGF receptor beta can trigger two rare diseases.
OMRF has received a five-year, $1.7 million grant to look at how DNA replicates itself.
Fish, frogs and worms have become key players in the fight against disease.